- No file added yet -
Exposure and Dosimetry Considerations for Adverse Outcome Pathways
presentation
posted on 2017-06-30, 13:51 authored by John Wambaugh, 0000-0002-4024-534XPresented at Adverse Outcome Pathways: From Research to Regulation
History
Usage metrics
Categories
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC